相关实验视频
Updated: Jun 16, 2025

07:01
Induction and Testing of Hypoxia in Cell Culture
Published on: August 12, 2011
84.8K
振荡性缺氧诱导的基因表达预测了人类乳腺癌患者的低生存率
Yasir Suhail1,2,3, Yamin Liu1,3, Wenqiang Du1
1Department of Biomedical Engineering, University of Connecticut Health, Farmington, Connecticut, USA.
Molecular carcinogenesis
|August 16, 2024
概括
振荡性缺氧,与稳定条件不同,独特地改变了乳腺癌细胞中的基因表达. 这种动态的氧气波动驱动恶性瘤,并预测癌症患者的生存率不佳.
科学领域:
- 癌症生物学 癌症生物学
- 瘤微环境 瘤微环境
- 分子瘤学分子瘤学
背景情况:
- 缺氧是瘤微环境中的关键因素,影响癌症转移.
- 转录因子低氧诱导因子1 (HIF-1) 是细胞对低氧反应的关键调节者.
- 对于动态 (振荡式) 缺氧对癌症进展的影响的了解有限.
研究的目的:
- 为了研究在三阴性乳腺癌中由振荡性缺氧诱导的特定基因表达变化.
- 为了比较振荡性与稳定性低氧对癌细胞恶性瘤的影响.
- 为了确定在人类癌症中振荡性低氧相关基因特征的临床相关性.
主要方法:
- 使用了MDA-MB-231细胞,这是三阴性乳腺癌的模型,在受控的振荡性缺氧下.
- 测量基因表达在响应振荡性缺氧时的变化.
- 分析了来自人类癌症样本的癌症基因组图谱 (TCGA) RNA-seq数据.
主要成果:
- 与稳定的缺氧相比,振荡性缺氧会诱导不同的基因表达模式,有时会产生相反的效果.
- 在MDA-MB-231细胞中发现了振荡性缺氧特异性基因表达特征.
- 这种特征在各种人类癌症中更加丰富,并且与患者的生存率降低相关,特别是在乳腺癌中.
结论:
- 振荡性缺氧显著影响基因表达和癌症恶性异于稳定性缺氧.
- 鉴定到的振荡性缺氧基因特征是乳腺癌患者生存率差的预后标志物.
- 振荡性缺氧诱导了未折叠的蛋白质反应,导致生存率降低.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K

